These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

207 related items for PubMed ID: 31750863

  • 1. Predicting Hearing Loss After Radiotherapy and Cisplatin Chemotherapy in Patients With Head and Neck Cancer.
    Schuette A, Lander DP, Kallogjeri D, Collopy C, Goddu S, Wildes TM, Daly M, Piccirillo JF.
    JAMA Otolaryngol Head Neck Surg; 2020 Feb 01; 146(2):106-112. PubMed ID: 31750863
    [Abstract] [Full Text] [Related]

  • 2. Validation of Hearing Loss Prediction Tool for Cisplatin Chemotherapy and Radiation in Head and Neck Cancer Treatment.
    Deutsch BC, Collopy C, Kallogjeri D, Piccirillo JF.
    JAMA Otolaryngol Head Neck Surg; 2021 Feb 01; 147(2):182-189. PubMed ID: 33300954
    [Abstract] [Full Text] [Related]

  • 3. Prediction of Hearing Loss Due to Cisplatin Chemoradiotherapy.
    Theunissen EA, Zuur CL, Józwiak K, Lopez-Yurda M, Hauptmann M, Rasch CR, van der Baan S, de Boer JP, Dreschler WA, Balm AJ.
    JAMA Otolaryngol Head Neck Surg; 2015 Sep 01; 141(9):810-5. PubMed ID: 26291150
    [Abstract] [Full Text] [Related]

  • 4. Relative contributions of radiation and cisplatin-based chemotherapy to sensorineural hearing loss in head-and-neck cancer patients.
    Das N, Kaushal D, Patro SK, Pareek P, Dixit A, Soni K, Prakasan Nair N, Choudhury B, Goyal A.
    Acta Otolaryngol; 2021 Sep 01; 141(9):885-893. PubMed ID: 34486907
    [Abstract] [Full Text] [Related]

  • 5. Ototoxic effects of supradose cisplatin with sodium thiosulfate neutralization in patients with head and neck cancer.
    Madasu R, Ruckenstein MJ, Leake F, Steere E, Robbins KT.
    Arch Otolaryngol Head Neck Surg; 1997 Sep 01; 123(9):978-81. PubMed ID: 9305250
    [Abstract] [Full Text] [Related]

  • 6. Relative contributions of radiation and cisplatin-based chemotherapy to sensorineural hearing loss in head-and-neck cancer patients.
    Hitchcock YJ, Tward JD, Szabo A, Bentz BG, Shrieve DC.
    Int J Radiat Oncol Biol Phys; 2009 Mar 01; 73(3):779-88. PubMed ID: 18707819
    [Abstract] [Full Text] [Related]

  • 7. Audiometric patterns in ototoxicity of intra-arterial Cisplatin chemoradiation in patients with locally advanced head and neck cancer.
    Zuur CL, Simis YJ, Lansdaal PE, Rasch CR, Tange RA, Balm AJ, Dreschler WA.
    Audiol Neurootol; 2006 Mar 01; 11(5):318-30. PubMed ID: 16983183
    [Abstract] [Full Text] [Related]

  • 8. Comparison of radiation and chemoradiation-induced sensorineural hearing loss in head and neck cancer patients.
    Mahdavi SR, Rezaeyan A, Nikoofar A, Bakhshandeh M, Farahani S, Cheraghi S.
    J Cancer Res Ther; 2020 Mar 01; 16(3):539-545. PubMed ID: 32719264
    [Abstract] [Full Text] [Related]

  • 9. Audiological profile of patients treated for childhood cancer.
    Liberman PH, Goffi-Gomez MV, Schultz C, Novaes PE, Lopes LF.
    Braz J Otorhinolaryngol; 2016 Mar 01; 82(6):623-629. PubMed ID: 27156673
    [Abstract] [Full Text] [Related]

  • 10. Decreased hearing after combined modality therapy for head and neck cancer.
    Pearson SE, Meyer AC, Adams GL, Ondrey FG.
    Am J Otolaryngol; 2006 Mar 01; 27(2):76-80. PubMed ID: 16500467
    [Abstract] [Full Text] [Related]

  • 11. Risk factors of ototoxicity after cisplatin-based chemo-irradiation in patients with locally advanced head-and-neck cancer: a multivariate analysis.
    Zuur CL, Simis YJ, Lansdaal PE, Hart AA, Rasch CR, Schornagel JH, Dreschler WA, Balm AJ.
    Int J Radiat Oncol Biol Phys; 2007 Aug 01; 68(5):1320-5. PubMed ID: 17418969
    [Abstract] [Full Text] [Related]

  • 12. Radiation dose to the cochlea and its association with sensorineural hearing loss in head and neck cancer-A prospective study.
    Apoorva KV, Vijendra Shenoy S, Athiyamaan MS, Kabekkodu S, Kshithi K, Zuturu N.
    Am J Otolaryngol; 2023 Aug 01; 44(4):103914. PubMed ID: 37178536
    [Abstract] [Full Text] [Related]

  • 13. Statistical model for prediction of hearing loss in patients receiving cisplatin chemotherapy.
    Johnson A, Tarima S, Wong S, Friedland DR, Runge CL.
    JAMA Otolaryngol Head Neck Surg; 2013 Mar 01; 139(3):256-64. PubMed ID: 23429908
    [Abstract] [Full Text] [Related]

  • 14. Audiological findings in patients treated with radio- and concomitant chemotherapy for head and neck tumors.
    Dell'Aringa AH, Isaac ML, Arruda GV, Esteves MC, Dell'aringa AR, Júnior JL, Rodrigues AF.
    Radiat Oncol; 2009 Nov 15; 4():53. PubMed ID: 19912669
    [Abstract] [Full Text] [Related]

  • 15. The Role of Audiometry prior to High-Dose Cisplatin in Patients with Head and Neck Cancer.
    Caballero M, Mackers P, Reig O, Buxo E, Navarrete P, Blanch JL, Grau JJ.
    Oncology; 2017 Nov 15; 93(2):75-82. PubMed ID: 28511189
    [Abstract] [Full Text] [Related]

  • 16. Sensorineural hearing loss in patients with head and neck cancer after chemoradiotherapy and radiotherapy: a systematic review of the literature.
    Theunissen EA, Bosma SC, Zuur CL, Spijker R, van der Baan S, Dreschler WA, de Boer JP, Balm AJ, Rasch CR.
    Head Neck; 2015 Feb 15; 37(2):281-92. PubMed ID: 24478269
    [Abstract] [Full Text] [Related]

  • 17. Short-term cohort study on sensorineural hearing changes in head and neck radiotherapy.
    Cheraghi S, Nikoofar P, Fadavi P, Bakhshandeh M, Khoie S, Gharehbagh EJ, Farahani S, Mohebbi A, Vasheghani M, Zare M, Nikoofar A, Mahdavi SR.
    Med Oncol; 2015 Jul 15; 32(7):200. PubMed ID: 26071124
    [Abstract] [Full Text] [Related]

  • 18. The role of genetic variants in the prediction of hearing loss due to cisplatin chemoradiotherapy.
    Duinkerken CW, Chiodo S, Hueniken K, Hauptmann M, Jóźwiak K, Cheng D, Hope A, Liu G, Zuur CL.
    Cancer Med; 2024 Aug 15; 13(16):e7465. PubMed ID: 39159054
    [Abstract] [Full Text] [Related]

  • 19. A randomized controlled trial to test the efficacy of trans-tympanic injections of a sodium thiosulfate gel to prevent cisplatin-induced ototoxicity in patients with head and neck cancer.
    Rolland V, Meyer F, Guitton MJ, Bussières R, Philippon D, Bairati I, Leclerc M, Côté M.
    J Otolaryngol Head Neck Surg; 2019 Jan 16; 48(1):4. PubMed ID: 30651130
    [Abstract] [Full Text] [Related]

  • 20. Sensorineural hearing loss in combined modality treatment of nasopharyngeal carcinoma.
    Chen WC, Jackson A, Budnick AS, Pfister DG, Kraus DH, Hunt MA, Stambuk H, Levegrun S, Wolden SL.
    Cancer; 2006 Feb 15; 106(4):820-9. PubMed ID: 16421885
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 11.